• Xeljanz 1 mg/ml oral solution

  Form: solution, oral

  Active substance	Dosage
  TOFACITINIB CITRATE	1,62 mg

  ATC: L04A L04AF L04AF01

  Manufacturer: Pfizer Europe Ma Eeig

• Xeljanz 10 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  TOFACITINIB CITRATE	16,155 mg

  ATC: L04A L04AF L04AF01

  Manufacturer: Pfizer Europe Ma Eeig

• Xeljanz 11 mg prolonged-release tablets

  Form: tablets, prolonged-release

  Active substance	Dosage
  TOFACITINIB CITRATE	17,77 mg

  ATC: L04A L04AF L04AF01

  Manufacturer: Pfizer Europe Ma Eeig

• Xeljanz 5 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  TOFACITINIB CITRATE	8,078 mg

  ATC: L04A L04AF L04AF01

  Manufacturer: Pfizer Europe Ma Eeig